tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SMMT Stock Latest News

Summit Therapeutics Reports Positive Phase III Trial Results
Company AnnouncementsSummit Therapeutics Reports Positive Phase III Trial Results
20h ago
8K
SMMT
Akeso to announces results from OS analysis of Phase III HARMONi-A study
PremiumThe Fly
Akeso to announces results from OS analysis of Phase III HARMONi-A study
9d ago
SMMT
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
PremiumStock Analysis & Ideas
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
9d ago
CSX
SMMT
Summit Therapeutics files to sell 26.68M shares of common stock for holders
PremiumThe Fly
Summit Therapeutics files to sell 26.68M shares of common stock for holders
10d ago
SMMT
Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer for NSCLC Treatment
PremiumCompany Announcements
Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer for NSCLC Treatment
12d ago
SMMT
Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer in NSCLC Treatment
PremiumCompany AnnouncementsSummit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer in NSCLC Treatment
12d ago
SMMT
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
12d ago
FUSE
NEUP
Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
Premium
Ratings
Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
15d ago
SMMT
Summit Therapeutics jumps after CAO buys $500,000 shares
PremiumThe Fly
Summit Therapeutics jumps after CAO buys $500,000 shares
16d ago
SMMT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
IBIO
NEUP
Summit Therapeutics Faces Financial Uncertainty: Potential Impact on Operations and R&D
PremiumCompany Announcements
Summit Therapeutics Faces Financial Uncertainty: Potential Impact on Operations and R&D
16d ago
SMMT
Summit Therapeutics Raises $500M in Private Placement
PremiumCompany Announcements
Summit Therapeutics Raises $500M in Private Placement
17d ago
8K
SMMT
Summit Therapeutics to sell 26.68M shares at $18.74 in private placement
PremiumThe FlySummit Therapeutics to sell 26.68M shares at $18.74 in private placement
17d ago
SMMT
Summit Therapeutics price target lowered to $40 from $50 at H.C. Wainwright
Premium
The Fly
Summit Therapeutics price target lowered to $40 from $50 at H.C. Wainwright
18d ago
SMMT
Summit Therapeutics price target raised to $16 from $13 at Barclays
Premium
The Fly
Summit Therapeutics price target raised to $16 from $13 at Barclays
18d ago
SMMT
Summit Therapeutics Advances Ivonescimab Development Amid Financial Growth
PremiumCompany Announcements
Summit Therapeutics Advances Ivonescimab Development Amid Financial Growth
18d ago
SMMT
Summit Therapeutics Launches New Phase III Study
PremiumCompany Announcements
Summit Therapeutics Launches New Phase III Study
19d ago
8K
SMMT
Summit Therapeutics price target lowered to $32 from $33 at Clear Street
PremiumThe Fly
Summit Therapeutics price target lowered to $32 from $33 at Clear Street
19d ago
SMMT
Morning Movers: Cleveland-Cliffs surges following earnings report
PremiumThe Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
19d ago
CLF
COO
Options Volatility and Implied Earnings Moves Today, October 20, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, October 20, 2025
19d ago
DX
CCK
Summit Therapeutics reports Q3 non-GAAP EPS (13c), consensus (4c)
Premium
The Fly
Summit Therapeutics reports Q3 non-GAAP EPS (13c), consensus (4c)
19d ago
SMMT
Ivonescimab’s Promising Trial Results Reinforce Buy Rating for Summit Therapeutics
Premium
Ratings
Ivonescimab’s Promising Trial Results Reinforce Buy Rating for Summit Therapeutics
19d ago
SMMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >